SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 249.44 |
Enterprise Value ($M) | 169.10 |
Book Value ($M) | -77.19 |
Book Value / Share | -1.81 |
Price / Book | -3.23 |
NCAV ($M) | -122.92 |
NCAV / Share | -2.89 |
Price / NCAV | -2.03 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | n/a |
Return on Assets (ROA) | -0.26 |
Return on Equity (ROE) | n/a |
Liquidity (mrq) | |
---|---|
Quick Ratio | 4.11 |
Current Ratio | 4.11 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 240.18 |
Assets | 285.92 |
Liabilities | 363.11 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 34.16 |
Operating Income | -107.91 |
Net Income | -98.43 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -118.11 |
Cash from Investing | 144.45 |
Cash from Financing | 1.78 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Fmr Llc | 6.66 | -9.86 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
6,287 | 56,478 | 11.13 | |
12,143 | 21,078 | 57.61 | |
3,824 | 15,367 | 24.88 | |
4,446 | 7,780 | 57.15 | |
(click for more detail) |
Similar Companies | |
---|---|
ETON – Eton Pharmaceuticals, Inc. | FATE – Fate Therapeutics, Inc. |
FBLG – FibroBiologics, Inc. | FOLD – Amicus Therapeutics, Inc. |
FULC – Fulcrum Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io